LOAMU
WST icon

Lombard Odier Asset Management (USA)’s West Pharmaceutical WST Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,557
Closed -$408K – 444
2025
Q3 		$408K Buy
1,557
+53
+4% +$12.9K 0.03% 310
2025
Q2 		$329K Buy
+1,504
New +$322K 0.03% 294

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Generation Investment Management
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s WST Position: Q4 2025 in Review

Lombard Odier Asset Management (USA) sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 1,557 shares — an estimated $408K sold.

Lombard Odier Asset Management (USA) first reported a position in WST in Q2 2025 and held it in 2 quarters. The position peaked at $408K in Q3 2025. 805 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • Lombard Odier Asset Management (USA) reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 1,557 West Pharmaceutical shares in Q4 2025, an estimated $408K.
  • Lombard Odier Asset Management (USA) first reported a position in West Pharmaceutical in Q2 2025 and held it in 2 quarters.
  • Lombard Odier Asset Management (USA)'s West Pharmaceutical position peaked at $408K in Q3 2025.
  • 805 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2025, filed 17 Feb 2026.